Multilevel comparison of Indian Naja venoms and their cross-reactivity with Indian polyvalent antivenoms

Archana Deka, Siddarth Bhatia, Vishal Santra, Omesh Bharti, Hmar Lalremsanga, Gerard Martin, Wolfgang Wüster, John Benjamin Owens, Stuart Graham, Robin Doley, Anita Malhotra

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

123 Wedi eu Llwytho i Lawr (Pure)

Crynodeb

Snake envenoming is caused by many biological species, rather than a single infectious agent, each with a multiplicity of toxins in their venom. Hence, developing effective treatments is challenging, especially in biodiverse and biogeographically complex countries such as India. The present study represents the first genus-wide proteomics analysis of venom composition across Naja species (N. naja, N. oxiana, and N. kaouthia) found in mainland India. Venom proteomes were consistent between individuals from the same localities in terms of the toxin families present, but not in the relative abundance of those in the venom. There appears to be more compositional variation among N. naja from different locations than among N. kaouthia. Immunoblotting and in vitro neutralization assays indicated cross-reactivity with Indian polyvalent antivenom, in which antibodies raised against N. naja are present. However, we observed ineffective neutralization of PLA2 activities of N. naja venoms from locations distant from the source of immunizing venoms. Antivenom immunoprofiling by antivenomics revealed differential antigenicity of venoms from N. kaouthia and N. oxiana, and poor reactivity towards 3FTxs and PLA2s. Moreover, there was considerable variation between antivenoms from different manufacturers. These data indicate that improvements to antivenom manufacturing in India are highly desirable.
Iaith wreiddiolSaesneg
Nifer y tudalennau24
CyfnodolynToxins
Cyfrol15
Rhif cyhoeddi4
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 1 Ebr 2023

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Multilevel comparison of Indian Naja venoms and their cross-reactivity with Indian polyvalent antivenoms'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn